Racial disparities in ovarian cancer incidence and mortality in Brazil: a population based analysis
Abstract
ObjectiveThis study aimed to assess racial disparities in the incidence and mortality of ovarian cancer in Brazil.MethodsData were obtained from three national sources: the Population-Based Cancer Registries (2010–2017), the Hospital-Based Cancer Registries, and the Mortality Information System (2000–2023). Crude and age-adjusted rates per 100,000 women were calculated by race (White vs. Black/Brown). Temporal trends were analyzed using Joinpoint regression, estimating the Annual Percent Change (APC).ResultsFrom 2010–2017, a total of 19,186 incident ovarian cancer cases were recorded, of which 61.9% occurred in White and 30.1% in Black/Brown women. Incidence rates declined among White women (APC –2.36%, p = 0.007) but remained stable among Black/Brown women (APC + 1.77%, p = 0.47). From 2000–2023, mortality increased among Black/Brown women (+1.85%/year, p < 0.001) and remained stable among White women (+0.11%/year, p = 0.39). Hospital-based data (n = 40,762) showed that Black/Brown women were younger (64.4% <60 years), less educated (55.6% <8 years), and more often lived in the Northeast region (53.2%). Compared with White women, they were less frequently staged at diagnosis (49.4% vs. 43.0%, p < 0.001), had longer delays to treatment initiation (≥60 days: 8.3% vs. 6.5%, p < 0.001), and higher early mortality rates (21.4% vs. 19.0%, p < 0.001).ConclusionsWhile ovarian cancer incidence is declining among White Brazilian women, Black/Brown women experience stable incidence and rising mortality. Socioeconomic vulnerability, regional disparities, and delays in treatment—rather than biological differences—appear to drive this gap. Implementing targeted policies to ensure equitable access to timely diagnosis and optimal care is essential to reduce these avoidable inequalities.
Related
- Racial, sex, and geographic disparities in mortality involving stroke and chronic kidney disease: a CDC WONDER database analysis, 1999–2020
- Trends and racial and ethnic disparities in prepregnancy obesity severity at first live birth in the US, 2015–2024: a population-based cross-sectional study
- Racial Disparities and Trends in Alzheimers and Parkinsons Disease-Related Mortality: A CDC WONDER Study 2018-2024
- Racial disparities in cancer burden, care pathways, and mortality among women in Brazil: a nationwide real-world analysis.
- The effect of regional disparities in access to rehabilitation services on mortality among stroke patients : A Korean nationwide population-based retrospective cohort study
BibTeX
@article{santos2026racial,
title = {{Racial disparities in ovarian cancer incidence and mortality in Brazil: a population based analysis}},
author = {Alexssandra Lima Siqueira dos Santos and Sofia Vidaurre Mendes and João Tadeu Fidelis Junior and Luís Felipe Leite and Luiz Claudio Santos Thuler and Andreia Cristina de Melo},
journal = {Frontiers in Oncology},
year = {2026},
month = nov,
doi = {10.3389/fonc.2026.1950349},
url = {https://www.frontiersin.org/articles/10.3389/fonc.2026.1950349},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Racial disparities in ovarian cancer incidence and mortality in Brazil: a population based analysis
AU - Alexssandra Lima Siqueira dos Santos
AU - Sofia Vidaurre Mendes
AU - João Tadeu Fidelis Junior
AU - Luís Felipe Leite
AU - Luiz Claudio Santos Thuler
AU - Andreia Cristina de Melo
PY - 2026
DA - 2026/11/04
JO - Frontiers in Oncology
DO - 10.3389/fonc.2026.1950349
UR - https://www.frontiersin.org/articles/10.3389/fonc.2026.1950349
AB - ObjectiveThis study aimed to assess racial disparities in the incidence and mortality of ovarian cancer in Brazil.MethodsData were obtained from three national sources: the Population-Based Cancer Registries (2010–2017), the Hospital-Based Cancer Registries, and the Mortality Information System (2000–2023). Crude and age-adjusted rates per 100,000 women were calculated by race (White vs. Black/Brown). Temporal trends were analyzed using Joinpoint regression, estimating the Annual Percent Change (APC).ResultsFrom 2010–2017, a total of 19,186 incident ovarian cancer cases were recorded, of which 61.9% occurred in White and 30.1% in Black/Brown women. Incidence rates declined among White women (APC –2.36%, p = 0.007) but remained stable among Black/Brown women (APC + 1.77%, p = 0.47). From 2000–2023, mortality increased among Black/Brown women (+1.85%/year, p < 0.001) and remained stable among White women (+0.11%/year, p = 0.39). Hospital-based data (n = 40,762) showed that Black/Brown women were younger (64.4% <60 years), less educated (55.6% <8 years), and more often lived in the Northeast region (53.2%). Compared with White women, they were less frequently staged at diagnosis (49.4% vs. 43.0%, p < 0.001), had longer delays to treatment initiation (≥60 days: 8.3% vs. 6.5%, p < 0.001), and higher early mortality rates (21.4% vs. 19.0%, p < 0.001).ConclusionsWhile ovarian cancer incidence is declining among White Brazilian women, Black/Brown women experience stable incidence and rising mortality. Socioeconomic vulnerability, regional disparities, and delays in treatment—rather than biological differences—appear to drive this gap. Implementing targeted policies to ensure equitable access to timely diagnosis and optimal care is essential to reduce these avoidable inequalities.
SN - 2234-943X
ER -